S1900K: A Randomized Phase II Study of Tepotinib with or without Ramucirumab in Participants with MET Exon 14 Skipping Positive Stage IV or Recurrent Non-small Cell Lung Cancer (Lung-Map Sub-Study)
- Title
- A Randomized Phase II Study of Tepotinib with or without Ramucirumab in Participants with MET Exon 14 Skipping Positive Stage IV or Recurrent Non-small Cell Lung Cancer (Lung-Map Sub-Study)
- Principal Investigator
- Bhasin, Pooja Gogia
- Phase
- II (Cancer Control)
- Age Group
- Adult
- Applicable Disease Sites
- Lung Cancer
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Rachel Harper
- Clinical Research Specialist
- Phone: +1 304-293-6066
- Email: rachel.harper@hsc.wvu.edu